Case Age/Sex | Diagnosis | Tumour Core I/Actin %a | Normal Core I/Actin %a | Level of Expression * | MIB-1b % |
---|---|---|---|---|---|
1 64/F | HFC | 46.2 ± 0.3 | 21.0 ± 0.5 | 2.2 | 1.1 |
2 33/M | HFC | 52.1 ± 1.8 | 22.8 ± 1.3 | 2.3 | 1.0 |
3 47/M | HFC | 52.1 ± 2.2 | 24.8 ± 1.1 | 2.1 | 0.9 |
4 59/F | HFC | 54.6 ± 0.8 | 22.2 ± 1.0 | 2.5 | 0.5 |
5 55/F | HFC | 47.7 ± 1.2 | 22.7 ± 0.8 | 2.1 | 0.9 |
6 24/F | HFC | 50.2 ± 0.9 | 23.9 ± 1.2 | 2.1 | 0.9 |
7 55/F | HFC | 41.5 ± 1.2 | 21.9 ± 1.4 | 1.9 | 0.8 |
8 64/F | FC | 46.4 ± 2.8 | 25.8 ± 1.6 | 1.8 | 1.1 |
9 46/F | FC | 48.9 ± 2.1 | 23.4 ± 0.8 | 2.1 | 1.6 |
10 71/F | HmFA | 47.2 ± 2.7 | 22.6 ± 1.8 | 2.1 | 1.1 |
11 24/F | mFA | 47.3 ± 3.3 | 26.4 ± 0.8 | 1.8 | 0.3 |
12 69/F | mFA | 45.1 ± 2.3 | 27.6 ± 1.3 | 1.6 | 0.0 |
13 57/F | mFA | 42.8 ± 1.8 | 22.5 ± 0.9 | 1.9 | 0.5 |
14 27/F | mFA | 48.8 ± 2.2 | 23.2 ± 1.1 | 2.1 | 0.9 |
15 53/F | mFA | 49.0 ± 2.1 | 22.7 ± 0.8 | 2.2 | 1.1 |
16 65/F | mFA | 52.4 ± 2.4 | 24.9 ± 0.9 | 2.1 | 0.7 |
17 31/F | mMFA | 35.8 ± 2.3 | 27.6 ± 1.3 | 1.3 | 0.1 |
18 52/F | PC | 30.0 ± 0.2 | 27.3 ± 0.1 | 1.1 | 0.7 |
19 46/F | PC | 24.2 ± 0.5 | 26.9 ± 0.1 | 0.9 | 1.1 |
20 52/F | PC | 39.8 ± 2.6 | 37.3 ± 0.0 | 1.1 | 0.7 |
21 47/F | PC | 26.7 ± 3.4 | 33.5 ± 3.7 | 0.8 | 3.0 |
22 52/F | PC | 16.7 ± 0.6 | 24.6 ± 0.4 | 0.7 | 0.7 |
23 68/F | PC | 24.1 ± 0.8 | 24.0 ± 0.6 | 1.0 | 0.8 |
24 60/F | HPC | 20.9 ± 1.2 | 23.2 ± 0.9 | 0.9 | 1.5 |
25 62/F | HPC | 16.4 ± 1.2 | 22.2 ± 0.8 | 0.7 | 0.4 |
26 11/M | HPC | 27.4 ± 0.9 | 22.8 ± 2.1 | 1.2 | 1.1 |
27 30/F | HMFA | 19.9 ± 0.1 | 28.6 ± 2.3 | 0.7 | 0.4 |
28 42/F | MFA | 18.5 ± 0.1 | 24.8 ± 0.1 | 0.7 | 0.6 |
29 52/F | MFA | 22.7 ± 2.3 | 25.4 ± 0.3 | 0.9 | 1.0 |
30 62/F | MFA | 22.3 ± 0.2 | 23.0 ± 0.1 | 1.0 | 0.2 |
31 54/F | MFA | 20.9 ± 0.7 | 25.8 ± 0.8 | 0.8 | 0.9 |